
PredOmix offers a blood test that detects cancer early by analyzing metabolism. It combines mass spectrometry with machine learning to read cancer-related changes in the blood metabolome. This is a health tech product for clinical use, serving hospitals, clinics, and diagnostic labs. The approach targets early-stage cancers and aims to scale across healthcare systems.

PredOmix offers a blood test that detects cancer early by analyzing metabolism. It combines mass spectrometry with machine learning to read cancer-related changes in the blood metabolome. This is a health tech product for clinical use, serving hospitals, clinics, and diagnostic labs. The approach targets early-stage cancers and aims to scale across healthcare systems.